Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Biol ; 20(8): 703-9, 2010 Apr 27.
Article in English | MEDLINE | ID: mdl-20346675

ABSTRACT

Intracellular Ca(2+) signals constitute key elements in signal transduction. Of the three major Ca(2+) mobilizing messengers described, the most potent, nicotinic acid adenine dinucleotide phosphate (NAADP) is the least well understood in terms of its molecular targets [1]. Recently, we showed that heterologous expression of two-pore channel (TPC) proteins enhances NAADP-induced Ca(2+) release, whereas the NAADP response was abolished in pancreatic beta cells from Tpcn2 gene knockout mice [2]. However, whether TPCs constitute native NAADP receptors is unclear. Here we show that immunopurified endogenous TPC complexes possess the hallmark properties ascribed to NAADP receptors, including nanomolar ligand affinity [3-5]. Our study also reveals important functional differences between the three TPC isoforms. Thus, TPC1 and TPC2 both mediate NAADP-induced Ca(2+) release, but the subsequent amplification of this trigger Ca(2+) by IP(3)Rs is more tightly coupled for TPC2. In contrast, TPC3 expression suppressed NAADP-induced Ca(2+) release. Finally, increased TPC expression has dramatic and contrasting effects on endolysosomal structures and dynamics, implicating a role for NAADP in the regulation of vesicular trafficking. We propose that NAADP regulates endolysosomal Ca(2+) storage and release via TPCs and coordinates endoplasmic reticulum Ca(2+) release in a role that impacts on Ca(2+) signaling in health and disease [6].


Subject(s)
Calcium Channels/metabolism , Calcium Signaling/physiology , Calcium/metabolism , Endosomes/metabolism , Lysosomes/metabolism , NADP/analogs & derivatives , Protein Isoforms/metabolism , Animals , Calcium Channels/genetics , Endosomes/ultrastructure , HEK293 Cells , Humans , Lysosomes/ultrastructure , NADP/metabolism , Protein Isoforms/genetics , Strongylocentrotus purpuratus/metabolism
2.
PLoS One ; 4(5): e5488, 2009.
Article in English | MEDLINE | ID: mdl-19424505

ABSTRACT

BACKGROUND: There is a major discrepancy between the in vitro and in vivo results regarding the role of beta1 integrins in the maintenance of epidermal stem/progenitor cells. Studies of mice with skin-specific ablation of beta1 integrins suggested that epidermis can form and be maintained in their absence, while in vitro data have shown a fundamental role for these adhesion receptors in stem/progenitor cell expansion and differentiation. METHODOLOGY/PRINCIPAL FINDINGS: To elucidate this discrepancy we generated hypomorphic mice expressing reduced beta1 integrin levels on keratinocytes that developed similar, but less severe defects than mice with beta1-deficient keratinocytes. Surprisingly we found that upon aging these abnormalities attenuated due to a rapid expansion of cells, which escaped or compensated for the down-regulation of beta1 integrin expression. A similar phenomenon was observed in aged mice with a complete, skin-specific ablation of the beta1 integrin gene, where cells that escaped Cre-mediated recombination repopulated the mutant skin in a very short time period. The expansion of beta1 integrin expressing keratinocytes was even further accelerated in situations of increased keratinocyte proliferation such as wound healing. CONCLUSIONS/SIGNIFICANCE: These data demonstrate that expression of beta1 integrins is critically important for the expansion of epidermal progenitor cells to maintain epidermal homeostasis.


Subject(s)
Epidermal Cells , Epidermis/metabolism , Integrin beta1/metabolism , Signal Transduction , Stem Cells/cytology , Stem Cells/metabolism , Aging/metabolism , Alleles , Animals , Cell Adhesion , Cell Count , Cell Proliferation , Codon, Nonsense/genetics , Crosses, Genetic , Female , Gene Deletion , Genotype , Heterozygote , Integrases/metabolism , Keratin-5/metabolism , Keratinocytes/cytology , Keratinocytes/metabolism , Male , Mice , Phenotype , Recombination, Genetic/genetics , Skin/metabolism , Skin/pathology
3.
J Clin Invest ; 119(4): 899-910, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19307725

ABSTRACT

The transcription factor serum response factor (SRF) plays a crucial role in the development of several organs. However, its role in the skin has not been explored. Here, we show that keratinocytes in normal human and mouse skin expressed high levels of SRF but that SRF expression was strongly downregulated in the hyperproliferative epidermis of wounded and psoriatic skin. Keratinocyte-specific deletion within the mouse SRF locus during embryonic development caused edema and skin blistering, and all animals died in utero. Postnatal loss of mouse SRF in keratinocytes resulted in the development of psoriasis-like skin lesions. These lesions were characterized by inflammation, hyperproliferation, and abnormal differentiation of keratinocytes as well as by disruption of the actin cytoskeleton. Ultrastructural analysis revealed markedly reduced cell-cell and cell-matrix contacts and loss of cell compaction in all epidermal layers. siRNA-mediated knockdown of SRF in primary human keratinocytes revealed that the cytoskeletal abnormalities and adhesion defects were a direct consequence of the loss of SRF. In contrast, the hyperproliferation observed in vivo was an indirect effect that was most likely a consequence of the inflammation. These results reveal that loss of SRF disrupts epidermal homeostasis and strongly suggest its involvement in the pathogenesis of hyperproliferative skin diseases, including psoriasis.


Subject(s)
Keratinocytes/metabolism , Keratinocytes/pathology , Serum Response Factor/deficiency , Serum Response Factor/genetics , Skin Diseases/metabolism , Skin Diseases/pathology , Actins/metabolism , Animals , Base Sequence , Cell Adhesion , Cell Differentiation , Cell Movement , Cell Proliferation , Cells, Cultured , DNA Primers/genetics , Desmosomes/pathology , Down-Regulation , Female , Humans , Mice , Mice, Mutant Strains , Mice, Transgenic , Pregnancy , Psoriasis/genetics , Psoriasis/metabolism , Psoriasis/pathology , RNA, Small Interfering/genetics , Serum Response Factor/antagonists & inhibitors , Skin/injuries , Skin/metabolism , Skin/pathology , Skin Diseases/genetics , Wound Healing/genetics , Wound Healing/physiology
4.
Am J Pathol ; 173(5): 1295-310, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18832567

ABSTRACT

Insulin-like growth factor 1 (IGF-1) is an important regulator of growth, survival, and differentiation in many tissues. It is produced in several isoforms that differ in their N-terminal signal peptide and C-terminal extension peptide. The locally acting isoform of IGF-1 (mIGF-1) was previously shown to enhance the regeneration of both muscle and heart. In this study, we tested the therapeutic potential of mIGF-1 in the skin by generating a transgenic mouse model in which mIGF-1 expression is driven by the keratin 14 promoter. IGF-1 levels were unchanged in the sera of hemizygous K14/mIGF-1 transgenic animals whose growth was unaffected. A skin analysis of young animals revealed normal architecture and thickness as well as proper expression of differentiation and proliferation markers. No malignant tumors were formed. Normal homeostasis of the putative stem cell compartment was also maintained. Healing of full-thickness excisional wounds was accelerated because of increased proliferation and migration of keratinocytes, whereas inflammation, granulation tissue formation, and scarring were not obviously affected. In addition, mIGF-1 promoted late hair follicle morphogenesis and cycling. To our knowledge, this is the first work to characterize the simultaneous, stimulatory effect of IGF-1 delivery to keratinocytes on two types of regeneration processes within a single mouse model. Our analysis supports the use of mIGF-1 for skin and hair regeneration and describes a potential cell type-restricted action.


Subject(s)
Cell Cycle , Hair Follicle/cytology , Hair Follicle/growth & development , Insulin-Like Growth Factor I/metabolism , Keratinocytes/metabolism , Wound Healing , Animals , Cell Differentiation , Cell Movement , Cell Proliferation , Epithelium/metabolism , Flow Cytometry , Gene Expression Regulation , Homeostasis , Insulin-Like Growth Factor I/genetics , Keratin-14/metabolism , Keratinocytes/cytology , Mice , Mice, Transgenic , Morphogenesis , Phenotype , Rats , Skin/cytology , Skin/growth & development , Stromal Cells/cytology , Transgenes
5.
Glia ; 53(2): 147-57, 2006 Jan 15.
Article in English | MEDLINE | ID: mdl-16206162

ABSTRACT

Regulated cell proliferation is a crucial prerequisite for Schwann cells to achieve myelination in development and regeneration. In the present study, we have investigated the function of the cell cycle inhibitors p21 and p16 as potential regulators of Schwann cell proliferation, using p21- or p16-deficient mice. We report that both inhibitors are required for proper withdrawal of Schwann cells from the cell cycle during development and following injury. Postnatal Schwann cells express p21 exclusively in the cytoplasm, first detectable at postnatal day 7. This cytoplasmic p21 expression is necessary for proper Schwann cell proliferation control in the late development of peripheral nerves. After axonal damage, p21 is found in Schwann cell nuclei during the initiation of the proliferation period. This stage is critically regulated by p21, since loss of p21 leads to a strong increase in Schwann cell proliferation. Unexpectedly, p21 levels are upregulated in this phase suggesting that the role of p21 may be more complex than purely inhibitory for the Schwann cell cycle. However, inhibition of Schwann cell proliferation is the overriding crucial function of p21 and p16 in peripheral nerves as revealed by the consequences of loss-of-function in development and after injury. Different mechanisms appear to underlie the inhibitory function, depending on whether p21 is cytoplasmic or nuclear.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p16/physiology , Cyclin-Dependent Kinase Inhibitor p21/physiology , Schwann Cells/drug effects , Adenoviridae/genetics , Animals , Blotting, Western , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cell Proliferation/drug effects , Fluorescent Antibody Technique , Genetic Vectors , Immunoenzyme Techniques , Keratinocytes/drug effects , Keratinocytes/metabolism , Mice , Nerve Fibers/physiology , Rats , Reverse Transcriptase Polymerase Chain Reaction , Sciatic Nerve/injuries , Skin/injuries , Skin/pathology , Transfection , Wound Healing
6.
Am J Physiol Cell Physiol ; 284(4): C944-52, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12620893

ABSTRACT

Recent evidence suggests that changes in membrane potential influence the proliferation and differentiation of keratinocytes. To further elucidate the role of changes in membrane potential for their biological fate, the electrical behavior of keratinocytes needs to be studied under complex conditions such as multilayered cultures. However, electrophysiological recordings from cells in the various layers of a complex culture would be extremely difficult. Given the high spatial resolution of confocal imaging and the availability of novel voltage-sensitive dyes, we combined these methods in an attempt to develop a viable alternative for recording membrane potentials in more complex tissue systems. As a first step, we used confocal ratiometric imaging of fluorescence resonance energy transfer (FRET)-based voltage-sensitive dyes. We then validated this approach by comparing the optically recorded voltage signals in HaCaT keratinocytes with the electrophysiological signals obtained by whole cell recordings of the same preparation. We demonstrate 1) that optical recordings allow precise multisite measurements of voltage changes evoked by the extracellular signaling molecules ATP and bradykinin and 2) that responsiveness to ATP differs in various layers of cultured keratinocytes.


Subject(s)
Adenosine Triphosphate/pharmacology , Fluorescence Resonance Energy Transfer , Keratinocytes/physiology , Keratinocytes/ultrastructure , Microscopy, Confocal , Cells, Cultured , Fluorescent Dyes , Humans , Keratinocytes/drug effects , Membrane Potentials/drug effects , Sensitivity and Specificity , Time Factors
7.
J Biol Chem ; 278(5): 3323-30, 2003 Jan 31.
Article in English | MEDLINE | ID: mdl-12421833

ABSTRACT

We used a combination of electrophysiological and cell and molecular biological techniques to study the regulation and functional role of the intermediate conductance Ca(2+)-activated K(+) channel, hIK1, in HaCaT keratinocytes. When we incubated cells with the hIK1 opener, 1-ethyl-2-benzimidazolinone (1-EBIO), to investigate the cellular consequences of prolonged channel activity, an unexpected down-regulation of channels occurred within a few hours. The same effect was produced by the hIK1 openers chlorzoxazone and zoxazolamine and was also observed in a different cell line (C6 glioma cells). After 3 days of treatment with 1-EBIO, mRNA levels of hIK1 were substantially diminished and no channel activity was detected. Down-regulation of hIK1 was accompanied by a loss of mitogenic activity and a strong increase in cell size. After withdrawal of 1-EBIO, hIK1 mRNA and channel activity fully recovered and the cells resumed mitogenic activity. Our data present evidence for a novel feedback mechanism of hIK1 expression that appears to result from the paradoxical action of its pharmacological activator during prolonged application. Because the down-regulation of hIK1 bears immediate significance on the biological fate of keratinocytes, 1-EBIO and related compounds might emerge as potent tools to influence the proliferation of various non-excitable cells endowed with IK channels.


Subject(s)
Benzimidazoles/pharmacology , Calcium Channel Agonists/pharmacology , Gene Expression Regulation/physiology , Ion Channel Gating/physiology , Keratinocytes/physiology , Potassium Channels, Calcium-Activated , Potassium Channels/genetics , Cell Division , Cell Line , Gene Expression Regulation/drug effects , Glioma , Humans , Intermediate-Conductance Calcium-Activated Potassium Channels , Ion Channel Gating/drug effects , Keratinocytes/cytology , Keratinocytes/drug effects , Kinetics , Membrane Potentials/drug effects , Membrane Potentials/physiology , Potassium Channels/drug effects , Potassium Channels/physiology , RNA, Messenger/genetics , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...